glyoxal bis(2-hydroxyanil) has been researched along with Congenital Myasthenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chevessier, F; Girard, E; Krejci, E; McArdle, JJ; Mersdorf, U; Peter, C; Witzemann, V | 1 |
Gomez, CM; Groshong, JS; Maselli, RA; Verity, MA; Vohra, BP; Wollmann, RL | 1 |
2 other study(ies) available for glyoxal bis(2-hydroxyanil) and Congenital Myasthenia
Article | Year |
---|---|
A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR εL221F mutation.
Topics: Acetylcholinesterase; Aminophenols; Animals; Biophysics; Diaphragm; Disease Models, Animal; Gene Expression Regulation; Genetic Predisposition to Disease; Hand Strength; Humans; In Vitro Techniques; Isoleucine; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Miniature Postsynaptic Potentials; Motor Endplate; Mutagenesis; Myasthenic Syndromes, Congenital; Neurofilament Proteins; Neuromuscular Junction; Patch-Clamp Techniques; Phenylalanine; Receptors, Nicotinic; S100 Proteins; Synaptophysin; Time Factors | 2012 |
Focal caspase activation underlies the endplate myopathy in slow-channel syndrome.
Topics: Age of Onset; Aminophenols; Apoptosis; Bungarotoxins; Calcium; Caspases; Cholinesterases; DNA Mutational Analysis; Enzyme Activation; Family Health; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Microscopy, Electron; Motor Endplate; Muscles; Mutation; Myasthenic Syndromes, Congenital; Neurologic Examination; Oligodeoxyribonucleotides, Antisense; Protein Subunits; Receptors, Cholinergic | 2004 |